Bio-Rad Laboratories, Inc. BIO.B Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $510.4M-1.0% | $532.2M+16.9% | $491.5M+19.3% | $534.2M+54.3% | $515.3M+48.7% | ||
| $153.2M-4.1% | $157.6M-4.8% | $154.7M-6.2% | $163.2M-3.3% | $159.8M-0.9% | ||
| $742M-27.5% | $669.3M-47.6% | $753.4M-37.5% | $928.7M-7.3% | $1.02B+14.8% | ||
| $767.5M-18.8% | $793.6M-28.2% | $851.7M-19.9% | $1.02B+20.5% | $945.7M+27.7% | ||
| —— | —— | —— | —— | —— | ||
| -$285.8M-150% | -$189.7M-18.4% | -$186M-223% | -$198.7M-1,657% | -$114.2M-340% | ||
| $241.4M-19.7% | $295.5M+45.1% | $295.5M-26.8% | $340M+4.0% | $300.8M-30.6% | ||
| $500K+66.7% | $500K+25.0% | $300K-45.6% | $400K-29.7% | $300K-48.7% | ||
| $14.9M-17.2% | $15.8M-17.7% | $15.8M-19.5% | $17.5M-10.9% | $18M-10.2% | ||
| -$232.8M+26.4% | -$286.5M-30.9% | -$312.7M+20.5% | -$356.2M-10.0% | -$316.5M+26.4% | ||
| —— | —— | —— | -$15.3M— | $4.7M— | ||
| -$14.1M— | $42.4M— | -$14M— | -$36M— | —— | ||
| $46.8M+1.1% | $46.6M+0.2% | $46.4M-0.7% | $46.3M-2.0% | $46.3M-2.4% | ||
| $66.5M-35.7% | $63.4M-36.2% | $79.8M-51.4% | $103.3M-31.2% | $103.5M-13.8% | ||
| $2.09B+5.1% | $2.06B0.0% | $2.04B-0.6% | $1.97B-8.6% | $1.99B-11.7% | ||
| —— | —— | —— | —— | —— | ||
| $2.63B+3.0% | $2.66B+4.0% | $2.59B-0.3% | $2.59B+0.1% | $2.55B-3.4% | ||
| $98M+13.2% | $81M-5.9% | $81.7M-4.3% | $84M-2.0% | $86.6M-14.5% | ||
| —— | -$38.1M-290% | -$23.55M-238% | -$9M-164% | $5.55M-50.3% | ||
| $60.2M-59.0% | $62M-68.9% | $88.8M-67.1% | $118.1M-62.4% | $146.7M-58.9% | ||
| $767.5M-18.8% | $793.6M-28.2% | $851.7M-19.9% | $1.02B+20.5% | $945.7M+27.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $15.8M-17.7% | $16.65M-12.5% | $17.5M-7.2% | $18.35M-1.7% | ||
| —— | -$16.9M-284% | -$10.38M-248% | -$3.85M-180% | $2.68M+2.9% | ||
| —— | $46.6M+0.2% | $46.58M-0.4% | $46.55M-1.0% | $46.53M-1.5% | ||
| $66.5M-35.7% | $63.4M-36.2% | $79.8M-51.4% | $103.3M-31.2% | $103.5M-13.8% | ||
| $357.2M+0.5% | $374.6M+29.4% | $336.8M+36.3% | $371M+109% | $355.5M+91.7% | ||
| $357.2M+0.5% | $374.6M+29.4% | $336.8M+36.3% | $371M+109% | $355.5M+91.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bio-Rad Laboratories, Inc. generate?
- Bio-Rad Laboratories, Inc. (BIO.B) generated $510.4M in operating cash flow over the trailing twelve months.
- What is Bio-Rad Laboratories, Inc.'s free cash flow?
- After $153.2M of capital expenditures, Bio-Rad Laboratories, Inc.'s free cash flow was $357.2M over the trailing twelve months, up 0.5% year over year.
- Where does Bio-Rad Laboratories, Inc.'s cash flow data come from?
- Every line is extracted from Bio-Rad Laboratories, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
